Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	6688.60	2143.94	-31.58
Graham Fair Price	-87.68	0.50	4.06
PEG	-14926.82	-2.18	-0.01
Price/Book	-55.05	3.46	7.71
Price/Cash Flow	42.53	-38.30	-66.64
Prices/Earnings	3072.24	221.21	-6.97
Price/Sales	-69.18	1.49	4.83
Price/FCF	42.53	-38.30	-66.64
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-54.24	0.04	-0.09
Operating Margin	98.09	< 0.005	-0.16
ROA	-98.89	< 0.005	-0.11
ROE	-0.28	< 0.005	-98.58
ROIC	-0.23	< 0.005	97.08
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.08	0.01	678.13
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-2.36	0.97	-58.77
EPS QOQ	-4.81	1.01	-78.89
FCF QOQ	-3.07	0.19	-93.96
Revenue QOQ	-0.13	0.52	295.48
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	80.32	88.14	9.74
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.06	0.05	-12.73
Quick Ratio	1.47	1.31	-11.08
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.63	1.69	3.52
Cash	1.22	1.04	-14.49
Capex	-0.04	-0.04	5.80
Free Cash Flow	-0.19	-0.15	19.03
Revenue	2.60	3.92	51.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.51	1.33	-11.92
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.39	-65.31	16702.34
Naive Interpretation	Member

06 - Financial Health · Weak

Rating